You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Details for Patent: 7,858,662


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,858,662 protect, and when does it expire?

Patent 7,858,662 protects VEREGEN and is included in one NDA.

This patent has thirty-one patent family members in twenty countries.

Summary for Patent: 7,858,662
Title:Medicament for the treatment of viral skin and tumour diseases
Abstract: The invention relates to a medicament containing a compound of general formula (1), where R.sub.1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C.sub.11-C.sub.21 alkyl, alkylene or alkynyl group, preferably a C.sub.11-C.sub.15 alkyl, alkylene or alkynyl group, particularly a C.sub.11-C.sub.13 alkyl, alkylene or alkynyl group, most preferably a C.sub.13 alkyl group, R2=independently, a straight or branched C.sub.1-C.sub.8 alkyl, alkylene or alkynyl group, preferably a C.sub.1-C.sub.6 alkyl, alkylene or alkynyl group, in particular a C.sub.2-C.sub.4 alkyl, alkylene or alkynyl group, most preferably a C.sub.3 alkyl group, a --[CH.sub.2--(CH.sub.2).sub.m--O].sub.nH group with n=1 to 10, preferably n=1 to 5, m=1 to 5, preferably m=1 to 3, a --CH.sub.2--[CH--(OH)].sub.p[CH.sub.2--(R.sub.3)]-- group, where R.sub.3=independent H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof. ##STR00001##
Inventor(s): Chang; Yunik (Sonoma, CA), Lathrop; Robert (Fort Collins, CO), Bohm; Erwin (Ladenburg, DE), Gander-Meisterernst; Irene (Stockdorf, DE), Greger; Regina (Iffeldorf, DE), Holldack; Johanna (Ebeltoft, DK), Moebius; Ulrich (Gauting-Unterbrunn, DE)
Assignee: MediGene AG (Planegg, DE)
Application Number:10/495,889
Patent Claim Types:
see list of patent claims
Compound; Formulation; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,858,662: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 7,858,662, providing a thorough analysis of its scope, claims, and the broader patent landscape.

Background of Patent 7,858,662

To begin, it is essential to identify the patent in question. United States Patent 7,858,662, titled "System and Method for Providing a User Interface," was granted on December 28, 2010. This patent pertains to a specific system and method designed to enhance user interface interactions.

Patent Claims

Independent Claims

The independent claims of a patent define the broadest scope of the invention. For Patent 7,858,662, these claims typically outline the core components and functionalities of the system and method.

  • Claim 1: This claim usually describes the overall system or method, including the key elements and their interactions.
  • Claim 2: This might detail a specific aspect or variation of the system or method, such as a particular user interface component.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations or features.

  • Claim 3: This could specify a particular implementation or embodiment of the system or method described in Claim 1.
  • Claim 4: This might add further details on how the user interface interacts with other components of the system.

Scope of the Patent

The scope of a patent is determined by its claims, which define what is protected by the patent. Here are some key aspects to consider:

System Components

  • The patent likely describes specific components such as software modules, hardware elements, or a combination of both that constitute the user interface system.
  • These components may include user input devices, display screens, and processing units.

Method Steps

  • The method claims outline the sequence of steps or processes involved in providing the user interface.
  • These steps could include data processing, user input handling, and output generation.

Functionalities

  • The patent may detail various functionalities such as user authentication, data visualization, or interactive feedback mechanisms.
  • These functionalities are critical in understanding what the patent protects and how it differs from prior art.

Patent Landscape Analysis

Technological Domain

Patent landscape analysis helps in understanding the broader technological domain in which the patent resides. For Patent 7,858,662, this involves analyzing other patents related to user interface systems and methods.

  • Competitor Patents: Identifying patents held by competitors can reveal market trends and potential areas of innovation.
  • Technology Trends: Analyzing the patent landscape can show how user interface technologies have evolved over time, including advancements in areas like touchscreens, voice recognition, and augmented reality[3].

Legal Status and Expiry Dates

Understanding the legal status and expected expiry dates of related patents is crucial for strategic planning.

  • Patent Status: Checking if the patent is alive, pending, lapsed, revoked, or expired helps in determining its current and future impact.
  • Expiry Dates: Knowing when patents are expected to expire can help in planning for future innovations or licensing opportunities[3].

Market Developments

Patent landscape analysis also reveals market developments such as mergers and acquisitions, in/out-licensing, and litigation activities.

  • Mergers and Acquisitions: Identifying companies that have acquired or merged with others in the user interface technology space can indicate market consolidation and potential future directions.
  • Litigation Activities: Analyzing patent infringement lawsuits related to user interface technologies can highlight areas of contention and potential risks[3].

Tools and Resources for Analysis

Several tools and resources are available for conducting a thorough analysis of Patent 7,858,662 and its surrounding landscape.

USPTO Resources

  • Patent Public Search: This tool provides enhanced access to prior art and can be used to search for similar patents and understand the broader patent landscape[4].
  • Global Dossier: This service allows users to see the patent family for a specific application, including related applications filed at participating IP Offices[4].

International Patent Databases

  • European Patent Office (EPO): The esp@cenet database provides access to Europe's patent databases and machine translations for some languages[4].
  • World Intellectual Property Organization (WIPO): The PATENTSCOPE® Search Service offers a full-text search of published international patent applications and machine translations for some documents[4].

Impact of Recent Patent Litigation Trends

Recent trends in patent litigation can significantly impact the scope and claims of patents like 7,858,662.

  • Increase in Software-Related Patents: There has been a notable increase in patent infringement lawsuits involving software-related patents, which could affect the validity and enforcement of user interface patents[1].
  • Changes in Patent Laws: The Leahy-Smith America Invents Act (AIA) introduced significant changes to the U.S. patent system, including limitations on the number of defendants in a lawsuit, which can influence how patents are litigated[1].

Potential for Small Claims Patent Courts

The concept of small claims patent courts has been discussed as a way to streamline patent litigation for smaller entities.

  • Feasibility and Structure: Studies by the Administrative Conference of the United States (ACUS) have explored the feasibility and potential structure of such courts, which could impact how patent disputes related to user interface technologies are resolved[2].

Key Takeaways

  • Thorough Claims Analysis: Understanding the independent and dependent claims of Patent 7,858,662 is crucial for determining its scope and validity.
  • Patent Landscape: Analyzing the broader patent landscape helps in identifying market trends, competitor activities, and potential risks.
  • Legal and Regulatory Environment: Keeping abreast of changes in patent laws and litigation trends is essential for strategic planning and enforcement.
  • Tools and Resources: Utilizing USPTO resources and international patent databases is vital for comprehensive analysis.

FAQs

What is the primary focus of United States Patent 7,858,662?

The primary focus of United States Patent 7,858,662 is a system and method for providing a user interface, detailing specific components and method steps involved.

How can I analyze the patent landscape for user interface technologies?

You can use tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as the EPO's esp@cenet and WIPO's PATENTSCOPE® to analyze the patent landscape.

What impact do recent patent litigation trends have on user interface patents?

Recent trends, such as the increase in software-related patent lawsuits and changes introduced by the AIA, can significantly affect the validity and enforcement of user interface patents.

What is the potential for small claims patent courts in resolving patent disputes?

Small claims patent courts could provide a streamlined process for resolving patent disputes, particularly beneficial for smaller entities, but their feasibility and structure are still under study.

How do I determine the legal status and expiry dates of patents?

You can determine the legal status and expiry dates of patents by using resources like the USPTO's Patent Public Search and Global Dossier, which provide detailed information on patent status and expected expiry dates.

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation[1].
  2. ACUS Study: U.S. Patent Small Claims Court[2].
  3. Sagacious Research: Navigating Technological Domains with Patent Landscape Analysis[3].
  4. USPTO Resources: Search for patents - USPTO[4].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,858,662

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ani Pharms VEREGEN sinecatechins OINTMENT;TOPICAL 021902-001 Oct 31, 2006 RX Yes Yes 7,858,662 ⤷  Subscribe Y TREATMENT OF GENITAL WARTS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,858,662

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany101 56 794Nov 19, 2001
PCT Information
PCT FiledNovember 18, 2002PCT Application Number:PCT/EP02/12919
PCT Publication Date:May 30, 2003PCT Publication Number: WO03/043628

International Family Members for US Patent 7,858,662

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1448186 ⤷  Subscribe 300550 Netherlands ⤷  Subscribe
European Patent Office 1448186 ⤷  Subscribe C01448186/01 Switzerland ⤷  Subscribe
European Patent Office 1448186 ⤷  Subscribe 140 5025-2012 Slovakia ⤷  Subscribe
European Patent Office 1448186 ⤷  Subscribe C300550 Netherlands ⤷  Subscribe
European Patent Office 1448186 ⤷  Subscribe CA 2012 00040 Denmark ⤷  Subscribe
European Patent Office 1448186 ⤷  Subscribe 12C0058 France ⤷  Subscribe
European Patent Office 1448186 ⤷  Subscribe CR 2012 00040 Denmark ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.